Strickland Metals Limited (ASX:STK)

Marinus Pharmaceuticals Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	328	188	65	70	33	8
Market Cap Growth	18.19%	188.31%	-7.50%	112.96%	294.64%	147.56%
Enterprise Value	316	160	65	58	32	8
Last Close Price	0.14	0.10	0.04	0.06	0.04	0.02
PS Ratio	282.88	-	-	293.59	-	-
PB Ratio	2.86	2.36	1.40	1.90	2.75	1.17
P/TBV Ratio	2.86	2.36	1.40	1.90	2.75	1.17
EV/Sales Ratio	272.53	-	-	242.58	-	-
Debt / Equity Ratio	0.01	0.00	0.01	0.01	-	-
Asset Turnover	0.01	-	-	0.01	-	-
Quick Ratio	15.43	8.12	0.63	1.96	4.03	1.33
Current Ratio	16.53	9.97	7.69	1.97	4.07	1.33
Return on Equity (ROE)	-3.66%	-10.41%	-5.78%	-17.09%	-40.15%	-11.09%
Return on Assets (ROA)	-2.90%	-4.10%	-3.38%	-10.08%	-24.63%	-6.74%
Return on Capital (ROIC)	-3.14%	-4.44%	-3.62%	-10.63%	-25.75%	-7.06%
Earnings Yield	-10.69%	-3.50%	-3.71%	-5.95%	-11.68%	-8.27%
FCF Yield	-8.12%	-8.87%	-24.47%	-28.37%	-17.71%	-19.20%
Buyback Yield / Dilution	-61.69%	-13.50%	-23.79%	-59.73%	-119.24%	-115.99%

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.